Ipci-comurnat.org » Clonazepam sale

Save the Pernambuco Trees

We have proved that we can survive in the most challenging of competitive environments, but must continue to move forward aggressively in order to fulfill the commitment we have made to our shareholders. To meet our customers’ demands for a broader product line, we also have an clonazepam sale expansion well underway at our injectable drug plant in Puerto Rico. Faulding Inc. 1, 1996 the company announced that its wholly-owned subsidiary, Purepac Pharmaceutical Co. , had received approval from the FDA to market clonazepam tablets, the generic equivalent of the anti-convulsant drug Klonopin(R), and that it expected to commence shipment of that product to customers early in calendar 1997. We anticipate FDA approval of two more of these drugs in this calendar year. 11, 1996–Teva Pharmaceutical Clonazepam sale industries Ltd. The Special Committee has retained clonazepam sale the law firm of White & Case to act as its independent legal counsel and Oppenheimer & Co. Limited, of its 834,188 shares of Class A Preferred Stock into 5,005,128 shares of Faulding Inc. -0- Note: Klonopin(R) is a registered trademark of Hoffman-LaRoche Inc. ELIZABETH, N. –(BUSINESS WIRE)–Nov. 1, Faulding has received seven ANDA approvals and clearance from the Food and Drug Administration to market four medical devices pursuant to 510k submissions. Clonazepam sale common stock terminated the company’s obligation to pay a cumulative quarterly dividend with respect to such stock. However, the rapid changes in the health-care industry clonazepam sale are presenting special challenges to each new quarter. Moldin said Faulding is addressing these challenges by seeking to increase its new product submissions to the Food and Drug Administration (FDA) and investing substantially in its new start-up clonazepam sale injectable drug and medical device businesses. For the fiscal year, the company’s leading product by sales was diclofenac tablets, the generic version of Voltaren(R), a non-steroidal, anti-inflammatory drug. Our new management team’s competence in timely drug development and regulatory approvals now compares very favorably to the best in the industry, said Moldin. At a price of $12 per share in cash. Looking forward, Moldin stated clonazepam sale that Faulding presently has seven product submissions on file with the FDA. 4, 1996– – Company has new Clonazepam approval and 14 submissions pending FDA approval Following its early 1996 restructuring and return to profitability in the quarter ended June 30, Faulding Inc. Had received five new generic drug approvals this year, and currently has 12 new Clonazepam sale generic drug and medical device products on file with the FDA. With both of these new products, we importantly could have the potential to participate in the formation of the generic market at patent expiration of the brand Clonazepam sale product, Moldin said. The company’s largest seller in the quarter was its recently launched clonazepam tablets, the generic version of Klonopin(R), an anti-convulsant drug.